MinervaX provides clinical and leadership update

MinervaX provides clinical and leadership update MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces clinical progress on its maternal GBS vaccine as well as multiple additions to its...